메뉴 건너뛰기




Volumn 17, Issue 10, 2015, Pages 1312-1321

Two heads better than one? Ipilimumab immunotherapy and radiation therapy for melanoma brain metastases

Author keywords

Brain metastases; ipilimumab; melanoma; radiation

Indexed keywords

BUDESONIDE; FOTEMUSTINE; GLYCOPROTEIN GP 100 VACCINE; IPILIMUMAB; PEPTIDE VACCINE; TEMOZOLOMIDE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY;

EID: 84943420158     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nov093     Document Type: Article
Times cited : (53)

References (68)
  • 1
    • 84857623883 scopus 로고    scopus 로고
    • Epidemiology of brain metastases
    • Nayak L, Lee EQ, Wen PY. Epidemiology of brain metastases. Curr Oncol Rep. 2012;14(1):48-54.
    • (2012) Curr Oncol Rep , vol.14 , Issue.1 , pp. 48-54
    • Nayak, L.1    Lee, E.Q.2    Wen, P.Y.3
  • 2
    • 4344694453 scopus 로고    scopus 로고
    • Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System
    • Barnholtz-Sloan JS, Sloan AE, Davis FG, et al. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol. 2004;22(14):2865-2872.
    • (2004) J Clin Oncol. , vol.22 , Issue.14 , pp. 2865-2872
    • Barnholtz-Sloan, J.S.1    Sloan, A.E.2    Davis, F.G.3
  • 3
    • 0018096512 scopus 로고
    • Malignant melanoma and central nervous system metastases: Incidence, diagnosis, treatment and survival
    • Amer MH, Al-Sarraf M, Baker LH, et al. Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival. Cancer. 1978;42(2):660-668.
    • (1978) Cancer , vol.42 , Issue.2 , pp. 660-668
    • Amer, M.H.1    Al-Sarraf, M.2    Baker, L.H.3
  • 4
    • 0031975369 scopus 로고    scopus 로고
    • Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma
    • Sampson JH, Carter JH Jr., Friedman AH, et al. Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg. 1998;88(1):11-20.
    • (1998) J Neurosurg , vol.88 , Issue.1 , pp. 11-20
    • Sampson, J.H.1    Carter, J.H.2    Friedman, A.H.3
  • 5
    • 0026718033 scopus 로고
    • The role of radiation therapy in the treatment of brain metastases
    • Coia LR. The role of radiation therapy in the treatment of brain metastases. Int J Radiat Oncol Biol Phys. 1992;23(1):229-238.
    • (1992) Int J Radiat Oncol Biol Phys , vol.23 , Issue.1 , pp. 229-238
    • Coia, L.R.1
  • 6
    • 38149075264 scopus 로고    scopus 로고
    • A new prognostic index and comparison to three other indices for patients with brain metastases: An analysis of 1,960 patients in the RTOG database
    • Sperduto PW, Berkey B, Gaspar LE, et al. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys. 2008;70(2):510-514.
    • (2008) Int J Radiat Oncol Biol Phys , vol.70 , Issue.2 , pp. 510-514
    • Sperduto, P.W.1    Berkey, B.2    Gaspar, L.E.3
  • 7
    • 77952567992 scopus 로고    scopus 로고
    • Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: A multi-institutional analysis of 4,259 patients
    • Sperduto PW, Chao ST, Sneed PK, et al. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys. 2010;77(3):655-661.
    • (2010) Int J Radiat Oncol Biol Phys , vol.77 , Issue.3 , pp. 655-661
    • Sperduto, P.W.1    Chao, S.T.2    Sneed, P.K.3
  • 8
    • 84916888200 scopus 로고    scopus 로고
    • Prognostic factors for overall survival after radiosurgery for brain metastases from melanoma
    • Marcus DM, Lowe M, Khan MK, et al. Prognostic factors for overall survival after radiosurgery for brain metastases from melanoma. Am J Clin Oncol 2014;37(6):580-4.
    • (2014) Am J Clin Oncol , vol.37 , Issue.6 , pp. 580-584
    • Marcus, D.M.1    Lowe, M.2    Khan, M.K.3
  • 9
    • 79953799396 scopus 로고    scopus 로고
    • Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma
    • Eigentler TK, Figl A, Krex D, et al. Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma. Cancer. 2011;117(8):1697-1703.
    • (2011) Cancer , vol.117 , Issue.8 , pp. 1697-1703
    • Eigentler, T.K.1    Figl, A.2    Krex, D.3
  • 10
    • 79955475531 scopus 로고    scopus 로고
    • Brain metastases as preventive and therapeutic targets
    • Steeg PS, Camphausen KA, Smith QR. Brain metastases as preventive and therapeutic targets. Nat Rev Cancer. 2011;11(5): 352-363.
    • (2011) Nat Rev Cancer , vol.11 , Issue.5 , pp. 352-363
    • Steeg, P.S.1    Camphausen, K.A.2    Smith, Q.R.3
  • 11
    • 79951966253 scopus 로고    scopus 로고
    • Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: Results of the EORTC 22952-26001 study
    • Kocher M, Soffietti R, Abacioglu U, et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol. 2011;29(2):134-141.
    • (2011) J Clin Oncol , vol.29 , Issue.2 , pp. 134-141
    • Kocher, M.1    Soffietti, R.2    Abacioglu, U.3
  • 12
    • 71249157772 scopus 로고    scopus 로고
    • Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: A randomised controlled trial
    • Chang EL,Wefel JS, Hess KR, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol. 2009;10(11):1037-1044.
    • (2009) Lancet Oncol , vol.10 , Issue.11 , pp. 1037-1044
    • Chang, E.L.1    Wefel, J.S.2    Hess, K.R.3
  • 13
    • 33744954692 scopus 로고    scopus 로고
    • Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: A randomized controlled trial
    • Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA. 2006;295(21):2483-2491.
    • (2006) JAMA , vol.295 , Issue.21 , pp. 2483-2491
    • Aoyama, H.1    Shirato, H.2    Tago, M.3
  • 14
    • 84911437178 scopus 로고    scopus 로고
    • Intracranial control and radiographic changes with adjuvant radiation therapy for resected brain metastases: Whole brain radiotherapy versus stereotactic radiosurgery alone
    • Patel KR, Prabhu RS, Kandula S, et al. Intracranial control and radiographic changes with adjuvant radiation therapy for resected brain metastases: whole brain radiotherapy versus stereotactic radiosurgery alone. J Neurooncol. 2014;120(3): 657-63.
    • (2014) J Neurooncol , vol.120 , Issue.3 , pp. 657-663
    • Patel, K.R.1    Prabhu, R.S.2    Kandula, S.3
  • 15
    • 0027984157 scopus 로고
    • Radiosensitivity of new and established human melanoma cell lines: Comparison of [3H]thymidine incorporation and soft agar clonogenic assays
    • Marshall ES, Matthews JH, Shaw JH, et al. Radiosensitivity of new and established human melanoma cell lines: comparison of [3H]thymidine incorporation and soft agar clonogenic assays. Eur J Cancer. 1994;30A(9):1370-1376.
    • (1994) Eur J Cancer , vol.30 A , Issue.9 , pp. 1370-1376
    • Marshall, E.S.1    Matthews, J.H.2    Shaw, J.H.3
  • 16
    • 73149104401 scopus 로고    scopus 로고
    • The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma
    • Agrawal S, Kane JM 3rd, Guadagnolo BA, et al. The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma. Cancer. 2009;115(24):5836-5844.
    • (2009) Cancer , vol.115 , Issue.24 , pp. 5836-5844
    • Agrawal, S.1    Kane, J.M.2    Guadagnolo, B.A.3
  • 17
    • 33750420947 scopus 로고    scopus 로고
    • Adjuvant radiotherapy for cutaneous melanoma: Comparing hypofractionation to conventional fractionation
    • Chang DT, Amdur RJ, Morris CG, et al. Adjuvant radiotherapy for cutaneous melanoma: comparing hypofractionation to conventional fractionation. Int J Radiat Oncol Biol Phys. 2006;66(4): 1051-1055.
    • (2006) Int J Radiat Oncol Biol Phys , vol.66 , Issue.4 , pp. 1051-1055
    • Chang, D.T.1    Amdur, R.J.2    Morris, C.G.3
  • 18
    • 79957541238 scopus 로고    scopus 로고
    • The evolving role of radiation therapy in the management of malignant melanoma
    • Khan N, Khan MK, Almasan A, et al. The evolving role of radiation therapy in the management of malignant melanoma. Int J Radiat Oncol Biol Phys. 2011;80(3):645-654.
    • (2011) Int J Radiat Oncol Biol Phys , vol.80 , Issue.3 , pp. 645-654
    • Khan, N.1    Khan, M.K.2    Almasan, A.3
  • 19
    • 79952264449 scopus 로고    scopus 로고
    • Outcome predictors of Gamma Knife surgery for melanoma brain metastases. Clinical article
    • Liew DN, Kano H, Kondziolka D, et al. Outcome predictors of Gamma Knife surgery for melanoma brain metastases. Clinical article. J Neurosurg. 2011;114(3):769-779.
    • (2011) J Neurosurg , vol.114 , Issue.3 , pp. 769-779
    • Liew, D.N.1    Kano, H.2    Kondziolka, D.3
  • 20
    • 3042559645 scopus 로고    scopus 로고
    • Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases
    • Selek U, Chang EL, Hassenbusch SJ 3rd, et al. Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases. Int J Radiat Oncol Biol Phys. 2004;59(4): 1097-1106.
    • (2004) Int J Radiat Oncol Biol Phys , vol.59 , Issue.4 , pp. 1097-1106
    • Selek, U.1    Chang, E.L.2    Hassenbusch, S.J.3
  • 21
    • 58949097456 scopus 로고    scopus 로고
    • Gamma Knife surgery in the management of radioresistant brain metastases in high-risk patients with melanoma, renal cell carcinoma, and sarcoma
    • Powell JW, Chung CT, Shah HR, et al. Gamma Knife surgery in the management of radioresistant brain metastases in high-risk patients with melanoma, renal cell carcinoma, and sarcoma. J Neurosurg. 2008;109(Suppl):122-128.
    • (2008) J Neurosurg , vol.109 , pp. 122-128
    • Powell, J.W.1    Chung, C.T.2    Shah, H.R.3
  • 22
    • 84872805876 scopus 로고    scopus 로고
    • Stereotactic radiosurgery for the treatment of melanoma and renal cell carcinoma brain metastases
    • Lwu S, Goetz P, Monsalves E, et al. Stereotactic radiosurgery for the treatment of melanoma and renal cell carcinoma brain metastases. Oncol Rep. 2013;29(2):407-412.
    • (2013) Oncol Rep , vol.29 , Issue.2 , pp. 407-412
    • Lwu, S.1    Goetz, P.2    Monsalves, E.3
  • 23
    • 84884903622 scopus 로고    scopus 로고
    • Challenges with the diagnosis and treatment of cerebral radiation necrosis
    • Chao ST, Ahluwalia MS, Barnett GH, et al. Challenges with the diagnosis and treatment of cerebral radiation necrosis. Int J Radiat Oncol Biol Phys. 2013;87(3):449-457.
    • (2013) Int J Radiat Oncol Biol Phys , vol.87 , Issue.3 , pp. 449-457
    • Chao, S.T.1    Ahluwalia, M.S.2    Barnett, G.H.3
  • 24
    • 0030060744 scopus 로고    scopus 로고
    • Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: Initial report of radiation therapy oncology group protocol (90-05)
    • Shaw E, Scott C, Souhami L, et al. Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: initial report of radiation therapy oncology group protocol (90-05). Int J Radiat Oncol Biol Phys. 1996;34(3): 647-654.
    • (1996) Int J Radiat Oncol Biol Phys , vol.34 , Issue.3 , pp. 647-654
    • Shaw, E.1    Scott, C.2    Souhami, L.3
  • 25
    • 79955876849 scopus 로고    scopus 로고
    • Stereotactic radiosurgery for brain metastases: Analysis of outcome and risk of brain radionecrosis
    • Minniti G, Clarke E, Lanzetta G, et al. Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis. Radiat Oncol. 2011;6:48.
    • (2011) Radiat Oncol , vol.6 , pp. 48
    • Minniti, G.1    Clarke, E.2    Lanzetta, G.3
  • 26
    • 84878649850 scopus 로고    scopus 로고
    • Hypofractionated radiosurgery for intact or resected brain metastases: Defining the optimal dose and fractionation
    • Eaton BR, Gebhardt B, Prabhu R, et al. Hypofractionated radiosurgery for intact or resected brain metastases: defining the optimal dose and fractionation. Radiat Oncol. 2013;8:135.
    • (2013) Radiat Oncol , vol.8 , pp. 135
    • Eaton, B.R.1    Gebhardt, B.2    Prabhu, R.3
  • 27
    • 0034614637 scopus 로고    scopus 로고
    • The hallmarks of cancer
    • Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000; 100(1):57-70.
    • (2000) Cell , vol.100 , Issue.1 , pp. 57-70
    • Hanahan, D.1    Weinberg, R.A.2
  • 28
    • 79952284127 scopus 로고    scopus 로고
    • Hallmarks of cancer: The next generation
    • Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646-674.
    • (2011) Cell , vol.144 , Issue.5 , pp. 646-674
    • Hanahan, D.1    Weinberg, R.A.2
  • 29
    • 55949083407 scopus 로고    scopus 로고
    • Anti-cytotoxic T-lymphocyte antigen-4 antibody: The first in an emerging class of immunomodulatory antibodies for cancer treatment
    • Fong L, Small EJ. Anti-cytotoxic T-lymphocyte antigen-4 antibody: the first in an emerging class of immunomodulatory antibodies for cancer treatment. J Clin Oncol. 2008;26(32):5275-5283.
    • (2008) J Clin Oncol , vol.26 , Issue.32 , pp. 5275-5283
    • Fong, L.1    Small, E.J.2
  • 30
    • 0029947568 scopus 로고    scopus 로고
    • Enhancement of antitumor immunity by CTLA-4 blockade
    • Leach DR, Krummel MF, Allison JP. Enhancement of antitumor immunity by CTLA-4 blockade. Science. 1996;271(5256):1734-1736.
    • (1996) Science , vol.271 , Issue.5256 , pp. 1734-1736
    • Leach, D.R.1    Krummel, M.F.2    Allison, J.P.3
  • 31
    • 0033592924 scopus 로고    scopus 로고
    • Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy
    • Kwon ED, Foster BA, Hurwitz AA, et al. Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy. Proc Natl Acad Sci USA. 1999;96(26): 15074-15079.
    • (1999) Proc Natl Acad Sci USA , vol.96 , Issue.26 , pp. 15074-15079
    • Kwon, E.D.1    Foster, B.A.2    Hurwitz, A.A.3
  • 32
    • 77955256254 scopus 로고    scopus 로고
    • Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: A multicenter single-arm phase II study
    • O'Day SJ, Maio M, Chiarion-Sileni V, et al. Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study. Ann Oncol. 2010;21(8):1712-1717.
    • (2010) Ann Oncol , vol.21 , Issue.8 , pp. 1712-1717
    • O'Day, S.J.1    Maio, M.2    Chiarion-Sileni, V.3
  • 33
    • 69949095926 scopus 로고    scopus 로고
    • A randomized, double-blind, placebo-controlled, phase II study comparing the tolerability and efficacy of ipilimumab administered with or without prophylactic budesonide in patients with unresectable stage III or IV melanoma
    • Weber J, Thompson JA, Hamid O, et al. A randomized, double-blind, placebo-controlled, phase II study comparing the tolerability and efficacy of ipilimumab administered with or without prophylactic budesonide in patients with unresectable stage III or IV melanoma. Clin Cancer Res. 2009;15(17): 5591-5598.
    • (2009) Clin Cancer Res , vol.15 , Issue.17 , pp. 5591-5598
    • Weber, J.1    Thompson, J.A.2    Hamid, O.3
  • 34
    • 75249100054 scopus 로고    scopus 로고
    • Ipilimumab monotherapy in patients with pretreated advanced melanoma: A randomised, double-blind, multicentre, phase 2, dose-ranging study
    • Wolchok JD, Neyns B, Linette G, et al. Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study. Lancet Oncol. 2010;11(2):155-164.
    • (2010) Lancet Oncol , vol.11 , Issue.2 , pp. 155-164
    • Wolchok, J.D.1    Neyns, B.2    Linette, G.3
  • 35
    • 73149092567 scopus 로고    scopus 로고
    • Guidelines for the evaluation of immune therapy activity in solid tumors: Immune-related response criteria
    • Wolchok JD, Hoos A, O'Day S, et al. Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria. Clin Cancer Res. 2009;15(23):7412-7420.
    • (2009) Clin Cancer Res , vol.15 , Issue.23 , pp. 7412-7420
    • Wolchok, J.D.1    Hoos, A.2    O'Day, S.3
  • 36
    • 84880511594 scopus 로고    scopus 로고
    • Development of ipilimumab: A novel immunotherapeutic approach for the treatment of advanced melanoma
    • Wolchok JD, Hodi FS, Weber JS, et al. Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma. Ann N Y Acad Sci. 2013;1291:1-13.
    • (2013) Ann N y Acad Sci , vol.1291 , pp. 1-13
    • Wolchok, J.D.1    Hodi, F.S.2    Weber, J.S.3
  • 37
    • 33748743268 scopus 로고    scopus 로고
    • CNS immune privilege: Hiding in plain sight
    • Carson MJ, Doose JM, Melchior B, et al. CNS immune privilege: hiding in plain sight. Immunol Rev. 2006;213:48-65.
    • (2006) Immunol Rev , vol.213 , pp. 48-65
    • Carson, M.J.1    Doose, J.M.2    Melchior, B.3
  • 38
    • 84873323242 scopus 로고    scopus 로고
    • Role of the systemic immune system in brain metastasis
    • Hamilton A, Sibson NR. Role of the systemic immune system in brain metastasis. Mol Cell Neurosci. 2013;53:42-51.
    • (2013) Mol Cell Neurosci , vol.53 , pp. 42-51
    • Hamilton, A.1    Sibson, N.R.2
  • 39
    • 84928898198 scopus 로고    scopus 로고
    • Unsanctifying the sanctuary: Challenges and opportunities with brain metastases
    • Puhalla S, ElmquistW, Freyer D, et al. Unsanctifying the sanctuary: challenges and opportunities with brain metastases. Neuro Oncol. 2015;17(5):639-651.
    • (2015) Neuro Oncol , vol.17 , Issue.5 , pp. 639-651
    • Puhalla, S.1    Elmquistw Freyer, D.2
  • 40
    • 84880573419 scopus 로고    scopus 로고
    • Pathologic and gene expression features of metastatic melanomas to the brain
    • Hamilton R, Krauze M, Romkes M, et al. Pathologic and gene expression features of metastatic melanomas to the brain. Cancer. 2013;119(15):2737-2746.
    • (2013) Cancer , vol.119 , Issue.15 , pp. 2737-2746
    • Hamilton, R.1    Krauze, M.2    Romkes, M.3
  • 41
    • 51149116051 scopus 로고    scopus 로고
    • CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS
    • Hodi FS, Oble DA, Drappatz J, et al. CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS. Nat Clin Pract Oncol. 2008; 5(9):557-561.
    • (2008) Nat Clin Pract Oncol , vol.5 , Issue.9 , pp. 557-561
    • Hodi, F.S.1    Oble, D.A.2    Drappatz, J.3
  • 42
    • 77954801079 scopus 로고    scopus 로고
    • Improved survival with ipilimumab in patients with metastatic melanoma
    • Hodi FS, O'Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363(8):711-723.
    • (2010) N Engl J Med , vol.363 , Issue.8 , pp. 711-723
    • Hodi, F.S.1    O'Day, S.J.2    McDermott, D.F.3
  • 43
    • 84858440498 scopus 로고    scopus 로고
    • Ipilimumab improves survival in previously treated, advanced melanoma patients with poor prognostic factors: Subgroup analyses from a phase III trial [abstract]
    • Lebbe C, McDermott DF, Robert C, et al. Ipilimumab improves survival in previously treated, advanced melanoma patients with poor prognostic factors: subgroup analyses from a phase III trial [abstract]. Ann Oncol. 2010;21(suppl 8):401.
    • (2010) Ann Oncol , vol.21 , pp. 401
    • Lebbe, C.1    McDermott, D.F.2    Robert, C.3
  • 44
    • 84860446616 scopus 로고    scopus 로고
    • Ipilimumab in patients with melanoma and brain metastases: An open-label, phase 2 trial
    • Margolin K, Ernstoff MS, Hamid O, et al. Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial. Lancet Oncol. 2012;13(5):459-465.
    • (2012) Lancet Oncol , vol.13 , Issue.5 , pp. 459-465
    • Margolin, K.1    Ernstoff, M.S.2    Hamid, O.3
  • 45
    • 79959772576 scopus 로고    scopus 로고
    • Ipilimumab plus dacarbazine for previously untreated metastatic melanoma
    • Robert C, Thomas L, Bondarenko I, et al. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N Engl J Med. 2011;364(26):2517-2526.
    • (2011) N Engl J Med , vol.364 , Issue.26 , pp. 2517-2526
    • Robert, C.1    Thomas, L.2    Bondarenko, I.3
  • 46
    • 84865567547 scopus 로고    scopus 로고
    • Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): An open-label, single-arm phase 2 trial
    • Di Giacomo AM, Ascierto PA, Pilla L, et al. Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial. Lancet Oncol. 2012; 13(9):879-886.
    • (2012) Lancet Oncol , vol.13 , Issue.9 , pp. 879-886
    • Di Giacomo, A.M.1    Ascierto, P.A.2    Pilla, L.3
  • 47
    • 80955130103 scopus 로고    scopus 로고
    • Safety and clinical activity of ipilimumab in melanoma patients with brain metastases: Retrospective analysis of data from a phase 2 trial
    • Weber JS, Amin A, Minor D, et al. Safety and clinical activity of ipilimumab in melanoma patients with brain metastases: retrospective analysis of data from a phase 2 trial. Melanoma Res. 2011;21(6):530-534.
    • (2011) Melanoma Res , vol.21 , Issue.6 , pp. 530-534
    • Weber, J.S.1    Amin, A.2    Minor, D.3
  • 48
    • 84901633374 scopus 로고    scopus 로고
    • Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases
    • Queirolo P, Spagnolo F, Ascierto PA, et al. Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases. J Neurooncol. 2014;118(1):109-16.
    • (2014) J Neurooncol , vol.118 , Issue.1 , pp. 109-116
    • Queirolo, P.1    Spagnolo, F.2    Ascierto, P.A.3
  • 49
    • 84864559660 scopus 로고    scopus 로고
    • Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival
    • Knisely JP, Yu JB, Flanigan J, et al. Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival. J Neurosurg. 2012;117(2):227-233.
    • (2012) J Neurosurg , vol.117 , Issue.2 , pp. 227-233
    • Knisely, J.P.1    Yu, J.B.2    Flanigan, J.3
  • 50
    • 84877043331 scopus 로고    scopus 로고
    • Ipilimumab in melanoma with limited brain metastases treated with stereotactic radiosurgery
    • Mathew M, Tam M, Ott PA, et al. Ipilimumab in melanoma with limited brain metastases treated with stereotactic radiosurgery. Melanoma Res. 2013;23(3):191-195.
    • (2013) Melanoma Res , vol.23 , Issue.3 , pp. 191-195
    • Mathew, M.1    Tam, M.2    Ott, P.A.3
  • 51
    • 84904216679 scopus 로고    scopus 로고
    • Ipilimumab and radiation therapy for melanoma brain metastases
    • Silk AW, Bassetti MF, West BT, et al. Ipilimumab and radiation therapy for melanoma brain metastases. Cancer Med. 2013; 2(6):899-906.
    • (2013) Cancer Med , vol.2 , Issue.6 , pp. 899-906
    • Silk, A.W.1    Bassetti, M.F.2    West, B.T.3
  • 52
    • 84921938937 scopus 로고    scopus 로고
    • Ipilimumab and whole brain radiation therapy for melanoma brain metastases
    • Gerber NK, Young RJ, Barker CA, et al. Ipilimumab and whole brain radiation therapy for melanoma brain metastases. J Neurooncol. 2015;121(1):159-165.
    • (2015) J Neurooncol , vol.121 , Issue.1 , pp. 159-165
    • Gerber, N.K.1    Young, R.J.2    Barker, C.A.3
  • 53
    • 84928938600 scopus 로고    scopus 로고
    • Stereotactic radiosurgery for melanoma brain metastases in patients receiving ipilimumab: Safety profile and efficacy of combined treatment
    • Kiess AP,Wolchok JD, Barker CA, et al. Stereotactic radiosurgery for melanoma brain metastases in patients receiving ipilimumab: safety profile and efficacy of combined treatment. Int J Radiat Oncol Biol Phys. 2015;92(2):368-75.
    • (2015) Int J Radiat Oncol Biol Phys , vol.92 , Issue.2 , pp. 368-375
    • Kiess, A.P.1    Wolchok, J.D.2    Barker, C.A.3
  • 54
    • 84867580941 scopus 로고    scopus 로고
    • Radiation necrosis of the brain in melanoma patients successfully treated with ipilimumab, three case studies
    • Du Four S, Wilgenhof S, Duerinck J, et al. Radiation necrosis of the brain in melanoma patients successfully treated with ipilimumab, three case studies. Eur J Cancer 2012;48(16):3045-3051.
    • (2012) Eur J Cancer , vol.48 , Issue.16 , pp. 3045-3051
    • Du Four, S.1    Wilgenhof, S.2    Duerinck, J.3
  • 55
    • 84953850731 scopus 로고    scopus 로고
    • Symptomatic histologically proven necrosis of brain following stereotactic radiation and ipilimumab in six lesions in four melanoma patients
    • Du Four S, Hong A, Chan M, et al. Symptomatic Histologically Proven Necrosis of Brain following Stereotactic Radiation and Ipilimumab in Six Lesions in Four Melanoma Patients. Case Rep Oncol Med. 2014;2014:417-913.
    • (2014) Case Rep Oncol Med , vol.2014 , pp. 417-913
    • Du Four, S.1    Hong, A.2    Chan, M.3
  • 56
    • 84952023257 scopus 로고    scopus 로고
    • Ipilimumab and Stereotactic Radiosurgery vs. Stereotactic Radiosurgery alone for Newly Diagnosed Melanoma Brain Metastases
    • In Press
    • Patel KR, Oliver DE, Rizzo M, et al. Ipilimumab and Stereotactic Radiosurgery vs. Stereotactic Radiosurgery alone for Newly Diagnosed Melanoma Brain Metastases. Am J Clin Oncol. 2015; In Press.
    • (2015) Am J Clin Oncol
    • Patel, K.R.1    Oliver, D.E.2    Rizzo, M.3
  • 57
    • 0029243776 scopus 로고
    • The effects of corticosteroids on lymphocyte recirculation in humans: Analysis of the mechanism of impaired lymphocyte migration to lymph node following methylprednisolone administration
    • Sackstein R, Borenstein M. The effects of corticosteroids on lymphocyte recirculation in humans: analysis of the mechanism of impaired lymphocyte migration to lymph node following methylprednisolone administration. J Investig Med. 1995;43(1): 68-77.
    • (1995) J Investig Med , vol.43 , Issue.1 , pp. 68-77
    • Sackstein, R.1    Borenstein, M.2
  • 58
    • 84891849910 scopus 로고    scopus 로고
    • Antitumor immune responses induced by ionizing irradiation and further immune stimulation
    • Frey B, Rubner Y, Kulzer L, et al. Antitumor immune responses induced by ionizing irradiation and further immune stimulation. Cancer Immunol, Immunother: 2014;63(1):29-36.
    • (2014) Cancer Immunol Immunother , vol.63 , Issue.1 , pp. 29-36
    • Frey, B.1    Rubner, Y.2    Kulzer, L.3
  • 59
    • 70149113060 scopus 로고    scopus 로고
    • Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: Changing strategies for cancer treatment
    • Lee Y, Auh SL, Wang Y, et al. Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment. Blood. 2009;114(3):589-595.
    • (2009) Blood , vol.114 , Issue.3 , pp. 589-595
    • Lee, Y.1    Auh, S.L.2    Wang, Y.3
  • 60
    • 33646704729 scopus 로고    scopus 로고
    • Radiation modulates the peptide repertoire, enhances MHC class i expression, and induces successful antitumor immunotherapy
    • Reits EA, Hodge JW, Herberts CA, et al. Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J Exp Med. 2006; 203(5):1259-1271.
    • (2006) J Exp Med , vol.203 , Issue.5 , pp. 1259-1271
    • Reits, E.A.1    Hodge, J.W.2    Herberts, C.A.3
  • 61
    • 1242315588 scopus 로고    scopus 로고
    • Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated
    • Demaria S, Ng B, Devitt ML, et al. Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. Int J Radiat Oncol Biol Phys. 2004;58(3):862-870.
    • (2004) Int J Radiat Oncol Biol Phys , vol.58 , Issue.3 , pp. 862-870
    • Demaria, S.1    Ng, B.2    Devitt, M.L.3
  • 62
    • 34248545443 scopus 로고    scopus 로고
    • Gene expression profiling of breast, prostate, and glioma cells following single versus fractionated doses of radiation
    • Tsai MH, Cook JA, Chandramouli GV, et al. Gene expression profiling of breast, prostate, and glioma cells following single versus fractionated doses of radiation. Cancer Res. 2007;67(8): 3845-3852.
    • (2007) Cancer Res , vol.67 , Issue.8 , pp. 3845-3852
    • Tsai, M.H.1    Cook, J.A.2    Chandramouli, G.V.3
  • 63
    • 0842266786 scopus 로고    scopus 로고
    • Interferon-gamma: An overview of signals, mechanisms and functions
    • Schroder K, Hertzog PJ, Ravasi T, et al. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol. 2004;75(2):163-189.
    • (2004) J Leukoc Biol , vol.75 , Issue.2 , pp. 163-189
    • Schroder, K.1    Hertzog, P.J.2    Ravasi, T.3
  • 64
    • 84857815877 scopus 로고    scopus 로고
    • Immunologic correlates of the abscopal effect in a patient with melanoma
    • Postow MA, Callahan MK, Barker CA, et al. Immunologic correlates of the abscopal effect in a patient with melanoma. N Engl J Med. 2012;366(10):925-931.
    • (2012) N Engl J Med , vol.366 , Issue.10 , pp. 925-931
    • Postow, M.A.1    Callahan, M.K.2    Barker, C.A.3
  • 65
    • 84943368706 scopus 로고    scopus 로고
    • Comparing radiation therapy and ipilimumab to Iipilimumab alone in metastatic melanoma patients [abstract 247]
    • April 19 Philadelphia
    • Patel KR, Liu YL, Shoukat S. Comparing radiation therapy and ipilimumab to Iipilimumab alone in metastatic melanoma patients [abstract 247]. In: American Association of Cancer Research Annual Meeting; April 19, 2015; Philadelphia.
    • (2015) American Association of Cancer Research Annual Meeting
    • Patel, K.R.1    Liu, Y.L.2    Shoukat, S.3
  • 66
    • 84888805558 scopus 로고    scopus 로고
    • Vemurafenib and ipilimumab: New agents for metastatic melanoma
    • Banaszynski M, Kolesar JM. Vemurafenib and ipilimumab: new agents for metastatic melanoma. Am J Health Syst Pharm. 2013;70(14):1205-1210.
    • (2013) Am J Health Syst Pharm , vol.70 , Issue.14 , pp. 1205-1210
    • Banaszynski, M.1    Kolesar, J.M.2
  • 67
    • 84888109114 scopus 로고    scopus 로고
    • Ipilimumab and vemurafenib: Two different routes for targeting melanoma
    • Burgeiro A, Mollinedo F, Oliveira PJ. Ipilimumab and vemurafenib: two different routes for targeting melanoma. Curr Cancer Drug Targets. 2013;13(8):879-94.
    • (2013) Curr Cancer Drug Targets , vol.13 , Issue.8 , pp. 879-894
    • Burgeiro, A.1    Mollinedo, F.2    Oliveira, P.J.3
  • 68
    • 84878875962 scopus 로고    scopus 로고
    • Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 mg/kg within an expanded access programme
    • Di Giacomo AM, Calabro L, Danielli R, et al. Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 mg/kg within an expanded access programme. Cancer Immunol Immunother. 2013;62(6):1021-1028.
    • (2013) Cancer Immunol Immunother , vol.62 , Issue.6 , pp. 1021-1028
    • Di Giacomo, A.M.1    Calabro, L.2    Danielli, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.